2025
SJR Q1
JCR Q1 · 4,8
22 matched articles
SCIE
Journal detail
Stem Cells
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1066509915494918
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,244
- Quartile Q1
- H-Index 264
- Cites/doc 4,43
- Docs (3y) 270
- Cites (3y) 1.142
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,8
- 5Y JIF 4,5
- JCI 0,77
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,244 | 4,8 | 4,5 | 0,77 | Q2 | 264 |
| 2024 | Q1 | Q2 | 1,287 | 3,6 | 4,4 | 0,84 | Q1 | 258 |
| 2023 | Q1 | Q1 | 1,396 | 4 | 4,9 | 0,92 | Q1 | 258 |
| 2022 | Q1 | Q1 | 1,339 | 5,2 | 5,8 | 0,98 | Q1 | 258 |
| 2021 | Q1 | Q1 | 1,374 | 5,8 | 7 | 1,09 | Q1 | 258 |
| 2020 | Q1 | Q1 | 2,159 | 6,3 | 6,8 | 1,31 | Q1 | 258 |
| 2019 | Q1 | Q1 | 2,181 | 6 | 5,8 | 1,38 | Q1 | 258 |
| 2018 | — | Q1 | — | 5,6 | 6 | 1,43 | Q1 | — |
| 2017 | Q1 | Q1 | 2,796 | 5,6 | 6,2 | 1,42 | Q1 | 258 |
| 2016 | Q1 | Q1 | 2,971 | 5,6 | 6,3 | — | — | 258 |
| 2015 | Q1 | Q1 | 3,435 | 5,9 | 6,9 | — | — | 258 |
| 2014 | Q1 | Q1 | 3,81 | 6,5 | 7,5 | — | — | 258 |
| 2013 | Q1 | Q1 | 4,334 | 7,1 | 8,3 | — | — | 258 |
| 2012 | Q1 | Q1 | 4,083 | 7,7 | 8,4 | — | — | 258 |
| 2011 | Q1 | Q1 | 4,734 | 7,8 | 8,6 | — | — | 258 |
| 2010 | Q1 | Q1 | 4,234 | 7,9 | 8,6 | — | — | 258 |
| 2009 | — | Q1 | — | 7,7 | 8,5 | — | — | — |
| 2008 | — | Q1 | — | 7,7 | 8,2 | — | — | — |
| 2007 | — | Q1 | — | 7,5 | 7,8 | — | — | — |
| 2006 | — | Q1 | — | 7,9 | — | — | — | — |
| 2005 | — | Q1 | — | 6,1 | — | — | — | — |
| 2004 | — | Q1 | — | 5,5 | — | — | — | — |
| 2003 | — | Q1 | — | 5,8 | — | — | — | — |
| 2002 | — | Q1 | — | 4 | — | — | — | — |
| 2001 | — | Q1 | — | 2,7 | — | — | — | — |
| 2000 | — | Q1 | — | 3 | — | — | — | — |
| 1999 | — | Q1 | — | 2,8 | — | — | — | — |
| 1998 | — | Q1 | — | 2,7 | — | — | — | — |
| 1997 | — | Q1 | — | 2,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 47/180 |
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q2 | 84/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 13/32 |
| 2025 | HEMATOLOGY | SCIE | Q1 | Q2 | 19/103 |
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 92/333 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 62/177 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q2 | 100/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 14/32 |
| 2024 | HEMATOLOGY | SCIE | Q2 | Q1 | 25/99 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q2 | 104/328 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 49/174 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 87/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 12/31 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q1 | 22/97 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 95/322 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 32/158 |
| 2022 | CELL BIOLOGY | SCIE | Q2 | Q2 | 73/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 9/29 |
| 2022 | HEMATOLOGY | SCIE | Q2 | Q1 | 22/79 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 72/241 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 33/159 |
| 2021 | CELL BIOLOGY | SCIE | Q2 | Q1 | 76/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 11/29 |
| 2021 | HEMATOLOGY | SCIE | Q2 | Q1 | 25/78 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q1 | 75/245 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 19/159 |
| 2020 | CELL BIOLOGY | SCIE | Q2 | Q1 | 58/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q1 | 9/29 |
| 2020 | HEMATOLOGY | SCIE | Q1 | Q1 | 15/76 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 59/242 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 18/156 |
| 2019 | CELL BIOLOGY | SCIE | Q1 | Q1 | 45/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 7/29 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 10/76 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 39/244 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 17/162 |
| 2018 | CELL BIOLOGY | SCIE | Q1 | Q1 | 41/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 4/26 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 12/73 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 41/230 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 15/161 |
| 2017 | CELL BIOLOGY | SCIE | Q1 | Q1 | 44/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q1 | 4/24 |
| 2017 | HEMATOLOGY | SCIE | Q1 | Q1 | 10/71 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 40/223 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 16/160 |
| 2016 | CELL BIOLOGY | SCIE | Q1 | — | 43/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 4/21 |
| 2016 | HEMATOLOGY | SCIE | Q1 | — | 12/70 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 37/217 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 14/161 |
| 2015 | CELL BIOLOGY | SCIE | Q1 | — | 34/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 3/21 |
| 2015 | HEMATOLOGY | SCIE | Q1 | — | 8/70 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 24/213 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 10/163 |
| 2014 | CELL BIOLOGY | SCIE | Q1 | — | 33/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/21 |
| 2014 | HEMATOLOGY | SCIE | Q1 | — | 4/68 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 20/211 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 11/165 |
| 2013 | CELL BIOLOGY | SCIE | Q1 | — | 33/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/18 |
| 2013 | HEMATOLOGY | SCIE | Q1 | — | 4/68 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 16/203 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 8/160 |
| 2012 | CELL BIOLOGY | SCIE | Q1 | — | 27/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/17 |
| 2012 | HEMATOLOGY | SCIE | Q1 | — | 4/67 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 14/197 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 7/158 |
| 2011 | CELL BIOLOGY | SCIE | Q1 | — | 27/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/12 |
| 2011 | HEMATOLOGY | SCIE | Q1 | — | 5/68 |
| 2011 | ONCOLOGY | SCIE | Q1 | — | 13/196 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 8/160 |
| 2010 | CELL BIOLOGY | SCIE | Q1 | — | 28/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/13 |
| 2010 | HEMATOLOGY | SCIE | Q1 | — | 5/66 |
| 2010 | ONCOLOGY | SCIE | Q1 | — | 13/185 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 6/152 |
| 2009 | CELL BIOLOGY | SCIE | Q1 | — | 22/162 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 2/12 |
| 2009 | HEMATOLOGY | SCIE | Q1 | — | 5/61 |
| 2009 | ONCOLOGY | SCIE | Q1 | — | 11/166 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 4/144 |
| 2008 | CELL BIOLOGY | SCIE | Q1 | — | 21/157 |
| 2008 | HEMATOLOGY | SCIE | Q1 | — | 6/62 |
| 2008 | ONCOLOGY | SCIE | Q1 | — | 11/143 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 5/138 |
| 2007 | CELL BIOLOGY | SCIE | Q1 | — | 20/156 |
| 2007 | HEMATOLOGY | SCIE | Q1 | — | 4/63 |
| 2007 | ONCOLOGY | SCIE | Q1 | — | 9/132 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 5/140 |
| 2006 | CELL BIOLOGY | SCIE | Q1 | — | 21/156 |
| 2006 | HEMATOLOGY | SCIE | Q1 | — | 4/61 |
| 2006 | ONCOLOGY | SCIE | Q1 | — | 9/127 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 7/139 |
| 2005 | CELL BIOLOGY | SCIE | Q1 | — | 27/153 |
| 2005 | HEMATOLOGY | SCIE | Q1 | — | 6/60 |
| 2005 | ONCOLOGY | SCIE | Q1 | — | 14/123 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 8/133 |
| 2004 | CELL BIOLOGY | SCIE | Q1 | — | 29/155 |
| 2004 | HEMATOLOGY | SCIE | Q1 | — | 7/62 |
| 2004 | ONCOLOGY | SCIE | Q1 | — | 15/123 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 9/132 |
| 2003 | CELL BIOLOGY | SCIE | Q1 | — | 27/156 |
| 2003 | HEMATOLOGY | SCIE | Q1 | — | 5/62 |
| 2003 | ONCOLOGY | SCIE | Q1 | — | 13/120 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 12/131 |
| 2002 | CELL BIOLOGY | SCIE | Q2 | — | 42/153 |
| 2002 | HEMATOLOGY | SCIE | Q1 | — | 9/61 |
| 2002 | ONCOLOGY | SCIE | Q1 | — | 20/114 |
| 2001 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 24/131 |
| 2001 | CELL BIOLOGY | SCIE | Q2 | — | 56/147 |
| 2001 | HEMATOLOGY | SCIE | Q1 | — | 14/59 |
| 2001 | ONCOLOGY | SCIE | Q2 | — | 37/107 |
| 2000 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 19/134 |
| 2000 | CELL BIOLOGY | SCIE | Q2 | — | 46/147 |
| 2000 | HEMATOLOGY | SCIE | Q1 | — | 13/60 |
| 2000 | ONCOLOGY | SCIE | Q1 | — | 24/103 |
| 1999 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 18/124 |
| 1999 | CELL BIOLOGY | SCIE | Q2 | — | 48/141 |
| 1999 | HEMATOLOGY | SCIE | Q1 | — | 15/60 |
| 1999 | ONCOLOGY | SCIE | Q2 | — | 27/105 |
| 1998 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 17/123 |
| 1998 | CELL BIOLOGY | SCIE | Q2 | — | 42/139 |
| 1998 | HEMATOLOGY | SCIE | Q1 | — | 14/59 |
| 1998 | ONCOLOGY | SCIE | Q1 | — | 24/104 |
| 1997 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 21/94 |
| 1997 | CELL BIOLOGY | SCIE | Q2 | — | 43/130 |
| 1997 | DEVELOPMENTAL BIOLOGY | SCIE | Q2 | — | 10/30 |
| 1997 | ONCOLOGY | SCIE | Q2 | — | 26/102 |